In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis

Fitoterapia

Volumn 73, Issue SUPPL. 1, 2002, Pages

  Ceschel, G C ^a   Maffei, P ^a   Sforzini, A ^a   Lombardi Borgia, S ^a   Yasin, A ^a   Ronchi, C ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MonteResearch   (Italy)

Author keywords

Caffeic acid phenetyl ester; In vitro permeation; Mucoadhesive gel; Porcine buccal mucosa; Propolis

Indexed keywords

ALCOHOL; CAFFEIC ACID PHENETHYL ESTER; PROPOLIS;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; MEMBRANE PERMEABILITY; NONHUMAN; NORMAL HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STEADY STATE; SWINE;

ADHESIVENESS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAFFEIC ACIDS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GELS; HUMANS; MALE; MOUTH MUCOSA; PERMEABILITY; PHENYLETHYL ALCOHOL; PHYTOTHERAPY; PROPOLIS; STOMATITIS; SWINE; TIME FACTORS;

PROPOLIS; SUIDAE;

EID: 0036863206     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0367-326X(02)00190-9     Document Type: Article

References (28)

1. Ghisalberti E. Bee World. 60:(59):1979;84.
2. Matsuda S.H. Foods Food Ingredients J Jpn. 160:(64):1994;73.
3. Wollenweber E., Buchmann S.T. Z Naturforsch. 52:1997;530-535.
4. Manolova N., Maximova V., Gegova G., et al. C R Acad Bulg Sci. 38:1985;735-738.
5. Koening B., Dustmann J.H. Naturwiss Rundsch. 41:1987;43-53.
6. Marcucci M.C. Apidologie. 26:1995;83-99.
7. Grange J.M., Davey R.W. J R Soc Med. 83:1990;159-160.
8. Bankova V., Christov R., Stoev G., Popov S. J Chromatogr. 607:1992;150-153.
9. Needleman P., Lang S., Johnson E.M. J Pharmacol Exp Ther. 181:1972;489-497.
10. Niitani H., Takano T., Takano K., Hiramori K., Kimata S., Ikeda M. Respir Circul. 32:1984;841-847.
11. Ceschel GC, Maffei P, Lombardi Borgia S. (2001). STP Pharm Sci in press.
12. Grunberger D., Banerjee R., Eisinger K., et al. Experientia. 44:1988;230-232.
13. Bhimani R.S., Troll W., Grunberger D., Frenkel K. Cancer Res. 53:1993;4528-4533.
14. Frenkel K., Wei H., Bhimani R.S., et al. Cancer Res. 53:1993;1255-1261.
15. Su Z.Z., Lin J., Grunberger D., Ficher P.B. Cancer Res. 54:1994;1865-1870.
16. Chen J.H., Shao Y., Huang M.T., Chin C.K., Ho C.T. Cancer Lett. 108:1996;211-214.
17. Huang M.T., Ma W., Yen P., et al. Carcinogenesis. 17:1996;761-765.
18. Na H.-K., Wilson M.R., Kang K.-S., Chang C.-C., Grunberger D., Trosko J.E. Cancer Lett. 157:2000;31-38.
19. Bronaugh R.L., Maibach H.I. Williams D.F. In vitro percutaneous absorption: principles, fundamentals and applications. 1991;146 CRC Press, Boca Raton, Florida.
20. Shah V.P., Elkins J., Hanus J., Noorizadeh C., Skelly J. Pharm Res. 8:1991;55-59.
21. Franz T.J. Invest Dermatol. 64:1975;190-196.
22. Friend D.R. J Cont Rel. 18:1992;235-248.
23. Zhang H., Robinson J.R. In vitro methods for measuring permeability of the oral mucosa. Rathbone M.J. Oral mucosal drug delivery. 1996;90-93 Marcel Dekker Inc, New York.
24. Park K., Cooper S.L., Robinson J.R. Bioadhesive hydrogel. Peppas N.A. Hydrogels in medicine and pharmacy: properties and applications. III:1987;137-175 CRC Boca Raton.
25. Ponchel G., Touchard F., Duchêne D., Peppas N.A. J Control Rel. 5:1987;129-141.
26. Peppas N.A., Mikos A.G. STP Pharma Sci. 5:1989;187-191.
27. Bouckaert S., Lefebvre A.R., Remon J.P. Pharm Res. 10:1993;853-859.
28. Walter K.A., Olejinik O., Harris S. Int Pharm Pharmacol. 36:1984;78-80.